These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36461870)

  • 1. Covid-19-associated rhino-orbito-cerebral mucormycosis (CAROM) in Delhi: Demographics and risk factors in a single-centre consecutive cohort of 200 inpatients.
    Singh A; Sikka K; Goel G; Kanodia A; Chandran A; Konkimalla A; Panda S; Garg RK; Xess I; Tandon N; Thakar A
    Natl Med J India; 2022; 35(3):132-137. PubMed ID: 36461870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting clinical outcome in COVID-associated rhino-orbito-cerebral mucormycosis (CAROM) patients-An ambispective, single-arm, observational study.
    Singh A; Goel G; Khan M; Kanodia A; Sikka K; Thakar A
    Am J Otolaryngol; 2023; 44(6):103975. PubMed ID: 37478538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors, mortality, and predictors of survival in COVID-19-associated pulmonary mucormycosis: a multicentre retrospective study from India.
    Muthu V; Agarwal R; Rudramurthy SM; Thangaraju D; Shevkani MR; Patel AK; Shastri PS; Tayade A; Bhandari S; Gella V; Savio J; Madan S; Hallur V; Maturu VN; Srinivasan A; Sethuraman N; Singh Sibia RP; Pujari S; Mehta R; Singhal T; Saxena P; Gupta V; Nagvekar V; Prayag P; Patel D; Xess I; Savaj P; Sehgal IS; Panda N; Rajagopal GD; Parwani RS; Patel K; Deshmukh A; Vyas A; Gandra RR; Sistla SK; Padaki PA; Ramar D; Sarkar S; Rachagulla B; Vallandaramam P; Premachandran KP; Pawar S; Gugale P; Hosamani P; Dutt SN; Nair S; Kalpakkam H; Badhwar S; Kompella KK; Singla N; Navlakhe M; Prayag A; Singh G; Dhakecha P; Chakrabarti A
    Clin Microbiol Infect; 2024 Mar; 30(3):368-374. PubMed ID: 38081413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
    Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
    Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.
    Reddy YM; Yeduguri S; Reddy N VS; Parida S; Kamatham SN; Pidaparthi L; Jaiswal SK; Sadhvani B; Tourani V; Kumar S; Challa S; Murthy JM
    J Mycol Med; 2022 May; 32(2):101252. PubMed ID: 35134736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes mellitus and other underlying conditions in patients with coronavirus disease 2019 associated rhino-orbito-cerebral mucormycosis: a systematic review and meta-analysis.
    Zobairy H; Salem MM; Ghajarzadeh M; Mirmosayyeb O; Mirsalehi M
    J Laryngol Otol; 2022 Sep; 136(9):788-798. PubMed ID: 35514092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
    Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
    Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
    Rao C; R M
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of stroke in patients with rhino cerebral mucormycosis seen during the second wave of COVID-19 pandemic: A prospective cohort study.
    Pandey S; Malhotra HS; Garg RK; Sharma K; Rizvi I; Kumar S; Kumar N; Uniyal R; Sharma PK; Gupta P; Jain A; Reddy DH
    J Infect Public Health; 2022 Nov; 15(11):1265-1269. PubMed ID: 36272391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
    Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
    Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
    Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
    Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased serum ferritin is associated with severity of orbital disease in COVID-19-associated rhino-orbito-cerebral mucormycosis: A quantitative analysis.
    Tanwar S; Mishra N; Sharma P; Kaur A
    Indian J Ophthalmol; 2024 Jul; ():. PubMed ID: 38990622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhino-orbital-cerebral mucormycosis: An epidemiological study from a tertiary care referral center in Western India.
    Patel R; Jethva J; Bhagat PR; Prajapati V; Thakkar H; Prajapati K
    Indian J Ophthalmol; 2022 Apr; 70(4):1371-1375. PubMed ID: 35326057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19-associated mucormycosis in India: Why such an outbreak?
    Pasquier G
    J Mycol Med; 2023 Aug; 33(3):101393. PubMed ID: 37182234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "MuCovid-21" study: Mucormycosis at an Indian tertiary care centre during the COVID-19 pandemic.
    Kumar S; Choudhary R; Pandey VP
    J R Coll Physicians Edinb; 2021 Dec; 51(4):352-358. PubMed ID: 34882132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
    Mehfooz S; Mehrotra N; Usmani T; Raj V
    Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
    Jog K; Nazirudeen R; Eagappan S; Santharam RK; Sridhar S
    Indian J Endocrinol Metab; 2023; 27(6):519-523. PubMed ID: 38371190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID Associated Mucormycosis: A Study on the Spectrum of Clinical, Biochemical and Radiological Findings in A Series of Ten Patients.
    Pal P; Chatterjee N; Ghosh S; Ray BK; Mukhopadhyay P; Bhunia K; Srivastava SR; Adhikari S; Barman D; Banerjee B; Mukhopadhyay M; Pal J
    J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.